June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Subthreshold Photocoagulation Treatment of Recurrent Central Serous Chorioretinopathy with Pachychoroid Pigment Epitheliopathy
Author Affiliations & Notes
  • Zhaoxia Zhang
    Shanxi Eye Hospital, Taiyuan, Shanxi, China
  • Bin Sun
    Shanxi Eye Hospital, Taiyuan, Shanxi, China
  • Juan Xie
    Shanxi Eye Hospital, Taiyuan, Shanxi, China
  • Guangping Hou
    Shanxi Eye Hospital, Taiyuan, Shanxi, China
  • Footnotes
    Commercial Relationships   Zhaoxia Zhang None; Bin Sun None; Juan Xie None; Guangping Hou None
  • Footnotes
    Support  Project Supported by the Natural Science Foundation of Shanxi Province, Grant No. 20210302123344; Project supported by the Shanxi Provincial Foundation for Returned Scholars, Grant No. 20200044; Project supported by Health Commission of Shanxi Province, Grant No. 2019077
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 3806 – F0227. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Zhaoxia Zhang, Bin Sun, Juan Xie, Guangping Hou; Subthreshold Photocoagulation Treatment of Recurrent Central Serous Chorioretinopathy with Pachychoroid Pigment Epitheliopathy. Invest. Ophthalmol. Vis. Sci. 2022;63(7):3806 – F0227.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Pachychoroid spectrum disorders are characterized by attenuation of the choriocapillaris overlying dilated choroidal veins, and associated with progressive retinal pigment epithelium dysfunction and neovascularization, including central serous chorioretinopathy (CSC) and pachychoroid pigment epitheliopathy (PPE). Subthreshold laser therapy is known to have RPE function as its main target. In this study, we evaluated subthreshold photocoagulation treatment for patients diagnosed with CSC and PPE.

Methods : Participants in this study were 7 patients (7 eyes; 4 males and 3 females) with CSC and PPE, who underwent enhanced depth imaging optical coherence tomography (EDI-OCT), fundus fluorescein angiography (FFA) and indocyanine green angiography (ICGA). Subthreshold photocoagulation was performed to treat pigment epithelial detachment (PED) at site of PPE outside of macular, which was performed with the following parameters: 5% duty cycle, 200 ms pulse duration, 160 µm spot size and 50% power of the barely visible threshold. Best corrected visual acuity (BCVA), the central choroidal thickness (CCT), and choroidal thickness (CT) at the lesion site of PPE were measured during follow-up.

Results : Of 7 eyes with recurrent CSC and PPE (Snellen< 20/40), FFA demonstrated one or multiple focal leaks at the level of RPE in 2 eyes, and multiple indistinct leaks in 5 eyes. ICGA showed multifocal areas of choroidal hyperpermeability as hyperfluorescent patches in the mid phase in all 7 eyes. EDI-OCT revealed macular serous retinal detachment (SRD) and irregular RPE elevation or PED outside of macular, CT increased at the lesion site of SRD and RPE characterized by dilated choroidal vessels in Haller’s layer (pachyvessels), accompanied by attenuation of choriocapillaris. After subthreshold photocoagulation at the site of PPE (e.g. PED) outside of macular, with the recovery of SRD and RPE lesion, CCT and CT decreased significantly (P<0.05).

Conclusions : In the eyes of recurrent CSC with PPE, subthreshold photocoagulation at the lesion site of PPE can resolve CSC within macular. Simultaneously, pachychoroid at the sites of CSC and PPE also improved. These results may support that PPE and CSC clinically overlap and have a common pathogenic background.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×